These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1243 related items for PubMed ID: 17599306

  • 1. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Zar FA, Bakkanagari SR, Moorthi KM, Davis MB.
    Clin Infect Dis; 2007 Aug 01; 45(3):302-7. PubMed ID: 17599306
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
    Pépin J, Valiquette L, Gagnon S, Routhier S, Brazeau I.
    Am J Gastroenterol; 2007 Dec 01; 102(12):2781-8. PubMed ID: 17900327
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment strategies for C. difficile associated diarrhea.
    Stepan C, Surawicz CM.
    Acta Gastroenterol Latinoam; 2007 Sep 01; 37(3):183-91. PubMed ID: 17955730
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness and appropriateness of empiric metronidazole for Clostridium difficile-associated diarrhea.
    Vasa CV, Glatt AE.
    Am J Gastroenterol; 2003 Feb 01; 98(2):354-8. PubMed ID: 12591054
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The changing face of Clostridium difficile: what treatment options remain?
    Shen EP, Surawicz CM.
    Am J Gastroenterol; 2007 Dec 01; 102(12):2789-92. PubMed ID: 18042108
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programs.
    Le F, Arora V, Shah DN, Salazar M, Palmer HR, Garey KW.
    Pharmacotherapy; 2012 Feb 01; 32(2):129-34. PubMed ID: 22392421
    [Abstract] [Full Text] [Related]

  • 19. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada.
    Pépin J, Routhier S, Gagnon S, Brazeau I.
    Clin Infect Dis; 2006 Mar 15; 42(6):758-64. PubMed ID: 16477549
    [Abstract] [Full Text] [Related]

  • 20. Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea.
    Juang P, Skledar SJ, Zgheib NK, Paterson DL, Vergis EN, Shannon WD, Ansani NT, Branch RA.
    Am J Infect Control; 2007 Mar 15; 35(2):131-7. PubMed ID: 17327194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.